Paul D. Rubin, Chief Medical Officer at BioAge Labs, Inc. (BIOA), sold 7,433 shares at $20.30 ($151K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Open-market sale of $151k BIOA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BIOA | SELL | 2026-01-06 | $191K | — | Filing → |
| BIOA | SELL | 2025-12-11 | $216K | — | Filing → |
| BIOA | SELL | 2025-12-05 | $1.4M | — | Filing → |